Literature DB >> 15615148

Sources, uses, strengths and limitations of data collected in primary care in England.

Azeem Majeed1.   

Abstract

In the UK, general practitioners are responsible for both providing primary care services and for organising referrals for specialist care. Consequently, the medical records held by general practitioners include details of all diagnoses and prescribed drugs, in many cases extending from birth. In an increasing number of general practices, these records are held in electronic format and are potentially available for extraction and analysis. Electronic data from general practice therefore offer unique opportunities to plan and monitor health services, measure the quality of care provided by the National Health Service, and undertake population-based research.

Mesh:

Year:  2004        PMID: 15615148

Source DB:  PubMed          Journal:  Health Stat Q        ISSN: 1465-1645


  49 in total

1.  Estimating STI morbidity in primary care.

Authors:  J A Cassell
Journal:  Sex Transm Infect       Date:  2006-02       Impact factor: 3.519

2.  Effect of a UK pay-for-performance program on ethnic disparities in diabetes outcomes: interrupted time series analysis.

Authors:  Riyadh Alshamsan; John Tayu Lee; Azeem Majeed; Gopalakrishnan Netuveli; Christopher Millett
Journal:  Ann Fam Med       Date:  2012 May-Jun       Impact factor: 5.166

3.  Recording ethnicity in primary care: assessing the methods and impact.

Authors:  Sally A Hull; Rohini Mathur; Ellena Badrick; John Robson; Kambiz Boomla
Journal:  Br J Gen Pract       Date:  2011-05       Impact factor: 5.386

4.  Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases.

Authors:  Kelvin Jordan; Alexandra M Clarke; Deborah P M Symmons; Douglas Fleming; Mark Porcheret; Umesh T Kadam; Peter Croft
Journal:  Br J Gen Pract       Date:  2007-01       Impact factor: 5.386

5.  Ethnic disparities in coronary heart disease management and pay for performance in the UK.

Authors:  Christopher Millett; Jeremy Gray; Martin Wall; Azeem Majeed
Journal:  J Gen Intern Med       Date:  2008-10-25       Impact factor: 5.128

6.  Does the pharmacy expenditure of patients always correspond with their morbidity burden? Exploring new approaches in the interpretation of pharmacy expenditure.

Authors:  Amaia Calderón-Larrañaga; Beatriz Poblador-Plou; Anselmo López-Cabañas; José Tomás Alcalá-Nalvaiz; José María Abad-Díez; Daniel Bordonaba-Bosque; Alexandra Prados-Torres
Journal:  BMC Public Health       Date:  2010-05-11       Impact factor: 3.295

7.  Use of a primary care database to determine trends in genital chlamydia testing, diagnostic episodes and management in UK general practice, 1990-2004.

Authors:  Gwenda Hughes; Tim Williams; Ian Simms; Catherine Mercer; Kevin Fenton; Jackie Cassell
Journal:  Sex Transm Infect       Date:  2007-03-14       Impact factor: 3.519

8.  Financial Incentives and Inequalities in Smoking Cessation Interventions in Primary Care: Before-and-After Study.

Authors:  Fiona L Hamilton; Anthony A Laverty; Kit Huckvale; Josip Car; Azeem Majeed; Christopher Millett
Journal:  Nicotine Tob Res       Date:  2015-05-19       Impact factor: 4.244

9.  Trends in sexually transmitted infections in general practice 1990-2000: population based study using data from the UK general practice research database.

Authors:  Jackie A Cassell; Catherine H Mercer; Lorna Sutcliffe; Irene Petersen; Amir Islam; M Gary Brook; Jonathan D Ross; George R Kinghorn; Ian Simms; Gwenda Hughes; Azeem Majeed; Judith M Stephenson; Anne M Johnson; Andrew C Hayward
Journal:  BMJ       Date:  2006-01-26

10.  The Use of Primary Care Big Data in Understanding the Pharmacoepidemiology of COVID-19: A Consensus Statement From the COVID-19 Primary Care Database Consortium.

Authors:  Hajira Dambha-Miller; Simon J Griffin; Duncan Young; Peter Watkinson; Pui San Tan; Ashley K Clift; Rupert A Payne; Carol Coupland; Jemma C Hopewell; Jonathan Mant; Richard M Martin; Julia Hippisley-Cox
Journal:  Ann Fam Med       Date:  2021 Mar-Apr       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.